Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Smart for Life, Inc. Common Stock (SMFL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/19/2025: SMFL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -100% | Avg. Invested days 10 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/19/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 0.28M USD | Price to earnings Ratio - | 1Y Target Price 8 |
Price to earnings Ratio - | 1Y Target Price 8 | ||
Volume (30-day avg) - | Beta 1.36 | 52 Weeks Range 0.00 - 3.31 | Updated Date 06/29/2025 |
52 Weeks Range 0.00 - 3.31 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -362.17 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -94.86% |
Management Effectiveness
Return on Assets (TTM) -21.69% | Return on Equity (TTM) -1870.79% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 14558638 | Price to Sales(TTM) 0.05 |
Enterprise Value 14558638 | Price to Sales(TTM) 0.05 | ||
Enterprise Value to Revenue 1.77 | Enterprise Value to EBITDA -3.69 | Shares Outstanding 7090730 | Shares Floating 6919841 |
Shares Outstanding 7090730 | Shares Floating 6919841 | ||
Percent Insiders 2.41 | Percent Institutions 0.64 |
Upturn AI SWOT
Smart for Life, Inc. Common Stock
Company Overview
History and Background
Smart for Life, Inc. (formerly known as Healthier Choices Management Corp.) was founded in 2007. The company has undergone a significant transformation, evolving from a focus on healthy food options to its current iteration as a biotechnology company specializing in the development and commercialization of innovative health and wellness products. A key milestone was its rebranding and strategic shift towards its current business focus.
Core Business Areas
- Bio-Active Drug Delivery Systems: Developing and commercializing proprietary drug delivery systems designed to enhance the efficacy and patient compliance of various therapeutics.
- Nutraceuticals and Supplements: Offering a range of science-backed nutraceuticals and dietary supplements aimed at improving overall health and well-being.
- Diagnostic and Therapeutic Solutions: Exploring and developing solutions for health diagnostics and therapeutics, with a focus on areas like metabolic health and longevity.
Leadership and Structure
Smart for Life, Inc. is led by a management team with experience in biotechnology, pharmaceuticals, and business development. The company operates with a lean structure, focusing on research and development, strategic partnerships, and commercialization efforts. Specific leadership roles and the exact organizational chart are typically detailed in their SEC filings.
Top Products and Market Share
Key Offerings
- Mena-Bioticsu2122 Technology: A proprietary bio-active drug delivery system designed to improve the absorption and efficacy of certain medications and supplements. Market share data is not readily available as this is a proprietary technology. Competitors in the drug delivery space are numerous and include large pharmaceutical companies and specialized biotech firms.
- Nutra-Lifeu2122 Brand Products: A line of nutraceuticals and dietary supplements targeting various health needs, such as weight management and metabolic health. Market share data for specific product lines within the highly fragmented supplement market is not publicly disclosed. Competitors include major supplement brands like NOW Foods, Nature's Bounty, and numerous smaller niche brands.
- Other Patented Technologies: The company holds patents for other technologies related to health and wellness, which are in various stages of development or commercialization. Specific product details and market share are not yet established.
Market Dynamics
Industry Overview
Smart for Life, Inc. operates within the rapidly growing biotechnology, pharmaceutical, and nutraceutical industries. The biotechnology sector is characterized by significant investment in R&D, innovation, and a high degree of regulatory scrutiny. The nutraceutical market is driven by increasing consumer awareness of health and wellness, preventative care, and a demand for natural and science-backed products. The drug delivery system market is driven by the need for improved therapeutic outcomes, reduced side effects, and enhanced patient convenience.
Positioning
Smart for Life, Inc. positions itself as an innovative company leveraging proprietary technologies to address unmet needs in health and wellness. Its competitive advantages lie in its intellectual property, including patents for its drug delivery systems and formulations. The company aims to carve out a niche by developing differentiated products that offer superior efficacy and patient benefits.
Total Addressable Market (TAM)
The total addressable market for Smart for Life's offerings spans multiple large industries, including the global pharmaceutical market (trillions of USD), the global dietary supplement market (billions of USD), and the specialized drug delivery market. Smart for Life is positioned to capture a segment of these markets by focusing on specific therapeutic areas and product categories where its proprietary technologies offer a distinct advantage. Its current market share is nascent, given its developmental stage in certain areas.
Upturn SWOT Analysis
Strengths
- Proprietary drug delivery technology (Mena-Bioticsu2122)
- Portfolio of patents and intellectual property
- Focus on high-growth health and wellness sectors
- Potential for synergistic product development
Weaknesses
- Limited operational history and established market presence
- Reliance on R&D and product pipeline success
- Potential funding challenges for significant R&D and commercialization efforts
- Brand recognition may be less established compared to larger competitors
Opportunities
- Growing demand for advanced drug delivery systems
- Increasing consumer interest in personalized health and nutraceuticals
- Strategic partnerships and licensing agreements
- Expansion into new therapeutic areas and global markets
- Acquisition of complementary technologies or companies
Threats
- Intense competition from established pharmaceutical and biotech companies
- Regulatory hurdles and lengthy approval processes for new drugs/therapies
- Challenges in scaling up manufacturing and distribution
- Patent challenges and intellectual property disputes
- Economic downturns impacting consumer spending on health products
Competitors and Market Share
Key Competitors
- Catalent, Inc. (CTLT)
- Lonza Group AG (LONN)
- Evonik Industries AG (EVK)
- Merck & Co., Inc. (MRK)
- Pfizer Inc. (PFE)
Competitive Landscape
Smart for Life, Inc. faces stiff competition from large, well-established pharmaceutical and biotechnology companies, as well as specialized contract development and manufacturing organizations (CDMOs). Its competitive advantages lie in its potentially unique bio-active drug delivery systems and its agility as a smaller player. However, it faces challenges in terms of R&D funding, regulatory navigation, and market penetration compared to its larger, more resourced competitors.
Growth Trajectory and Initiatives
Historical Growth: Smart for Life's historical growth has been characterized by strategic shifts, acquisitions, and investments in its technology pipeline. Revenue growth has been inconsistent, with periods of focus on developing its product offerings rather than immediate commercial sales. The company has been building its intellectual property portfolio and establishing its market presence.
Future Projections: Future projections for Smart for Life, Inc. are contingent on the successful development and commercialization of its Mena-Bioticsu2122 technology and other product candidates. Analyst estimates, if available, would focus on potential revenue generation from licensing deals, product sales, and the impact of successful clinical trials. The long-term growth trajectory is tied to its ability to navigate the regulatory landscape and gain market acceptance.
Recent Initiatives: Recent initiatives may include partnerships with research institutions, advancements in its drug delivery platform, potential new product launches, and efforts to strengthen its patent portfolio. Specific recent initiatives would be detailed in their latest press releases and SEC filings.
Summary
Smart for Life, Inc. is a biotechnology company with a focus on proprietary drug delivery systems and nutraceuticals. Its key strength lies in its intellectual property, particularly its Mena-Bioticsu2122 technology. The company operates in high-growth, competitive markets but faces challenges related to funding, regulatory approval, and establishing market share against larger players. Successful development and commercialization of its pipeline are crucial for future growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Financial News Outlets (e.g., Bloomberg, Reuters)
- Industry Research Reports
- Company Press Releases
Disclaimers:
This analysis is based on publicly available information and may not be exhaustive. Financial data and market share figures are estimates and subject to change. Investing in biotechnology and pharmaceutical companies carries significant risks. This information is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Smart for Life, Inc. Common Stock
Exchange NASDAQ | Headquaters Miami, FL, United States | ||
IPO Launch date 2022-02-16 | CEO, President & Director Mr. Darren Minton | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 12 | Website https://smartforlife.com |
Full time employees 12 | Website https://smartforlife.com | ||
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceuticals and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, and soups and shakes, as well as vitamins and supplement powders, tablets, and soft gels under the Smart for Life brand; dietary supplements; and nutritional products, including whey protein isolate powder, tablet supplements for joint health, nitric oxide, post workout blends, Omega-3 supplements, and pre-workout supplements under the GSP brand for athletes and active lifestyle consumers. The company provides various nutritional products, such as antioxidant rich supplements, plant-based proteins, alkalizing nutrients, and weight management products; and operates a cost per action/cost per acquisition network for digital marketers for product sale and lead generation. It retails its products through online market platforms and stores. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. The company was founded in 2002 and is based in Miami, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.